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Familial Polymorphic Ventricular Arrhythmias
A Quarter Century of Successful Medical
Treatment Based on Serial Exercise-Pharmacologic Testing
John D. Fisher, MD, FACC, Dennis Krikler, MD, FRCP, FACC,
Katherine A. Hallidie-Smith, MB, FRCP, FACC
London, United Kingdom
OBJECTIVES We sought to determine whether objective tests of antiarrhythmic drug efficacy could produce
favorable short- and long-term outcomes in a family with idiopathic malignant ventricular
arrhythmias.
BACKGROUND In 1973 a family presented with a history of several generations of syncopal spells and sudden
death. Some individuals had nonspecific electrocardiographic (ECG) changes. Their QT
intervals were normal at rest and with exercise. Autopsies in two young family members
showed no cardiac abnormalities, specifically no evidence of arrhythmogenic right ventricular
dysplasia, other cardiomyopathy, myocarditis or gross abnormality of the conduction system.
METHODS Available family members had screening ECGs. Symptomatic members had a battery of tests,
including electrophysiologic studies, ambulatory ECGs, audiograms, exercise stress testing,
serum catecholamine levels during rest and exercise and isoproterenol infusion. Serial
exercise-pharmacologic testing was performed in symptomatic family members until induc-
tion of an arrhythmia during exercise required higher work loads or became impossible.
RESULTS Arrhythmias were not induced during electrophysiologic studies. In several family members
tested, ventricular premature beats and then rapid polymorphic ventricular arrhythmias
occurred whenever the sinus rate exceeded 130 beats/min. Emotional stress, isoproterenol
infusion and exercise all elicited similar arrhythmias. Catecholamine levels during exercise
were, however, unequivocally normal in two of three family members tested. Beta-blockers
appeared to be the most effective pharmacologic agent for prevention of these arrhythmias.
The efficacy of treatment has been confirmed during a follow-up of 25 years.
CONCLUSIONS This family appears to have catecholamine hypersensitivity as the basis for their ventricular
arrhythmias. Guided therapy using serial exercise-pharmacologic testing provided reliable
protection for this familial ventricular arrhythmia during a 25-year follow-up. (J Am Coll
Cardiol 1999;34:2015–22) © 1999 by the American College of Cardiology
Familial ventricular tachycardia is usually attributable to
recognized conditions such as arrhythmogenic right ventric-
ular dysplasia (1–3), hypertrophic cardiomyopathy (4,5),
familial cardiomyopathy (6) or one of the long QT interval
syndromes (7–11). There are families with ventricular
tachycardias in which no recognized underlying condition
has been identified (12–19). Most of these families have
features not shared with the others. These features differ, in
turn, from those found in the family in the present report
(Table 1). In this family, members developed ventricular
arrhythmias during sinus tachycardia, whether induced by
exercise, isoproterenol infusion or emotion. Their QT
intervals were normal at rest and during exercise. This
family was first identified, evaluated and treated on the basis
of serial exercise-pharmacologic testing in 1973 to 1974. It
is now possible to report a quarter century of apparently
effective medical therapy.
FAMILY HISTORY
The propositus presented in November 1973; he was a
13-year-old boy from a small hamlet in Lincolnshire. He
had experienced syncope, often several times a week, for two
and a half years, always related to exercise or to excitement
such as catching a fish. The onset was sudden, with or
without previous dizziness. He would fall unconscious and
become pale, sometimes with gasping respiration. There
were never any tonic or clonic movements or frothing.
Recovery was complete within a few minutes.
There were 10 siblings, and at least six members of the
family had similar attacks (Fig. 1). The paternal great-
grandfather had died suddenly at an early age after having
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had many previous syncopal spells. The father had some
reduction in his spells after being treated with phenytoin on
the presumption that he had epilepsy. At times of general
excitement (e.g., watching football [soccer]), several mem-
bers of the family often fainted at the same time. These
attacks had not been considered serious until August 1973,
when the patient’s 16-year-old sister died in an attack
provoked by emotional stress. She had suffered as many as
four attacks per week but had otherwise seemed healthy.
One month later, a 21-year-old brother whose single
previous attack occurred in 1971, died while riding his
motorcycle. He suddenly swung around in the street, drove
over a curb and fell to the ground. There was no evidence of
ingestion of alcohol, and his body showed no sign of injury.
Autopsies were performed on both of these victims.
Autopsy of the 16-year-old girl showed lymphocytic infil-
tration in the portal tracts of the liver and in the lungs and
brain; death was reported as being due to subacute viral
encephalitis. The heart was normal on gross examination
and routine histologic study. Autopsy of the 21-year-old
man revealed no significant abnormality. After the family
came to our attention, the cardiac material was sent to a
cardiac pathologist (Dr. E. Olsen) for further analysis. In
neither case did the heart prove suitable for specialized
investigations of the small vessels and conducting systems,
but there were no gross or general histologic abnormalities
and specifically no evidence of arrhythmogenic right ven-
tricular dysplasia (when re-reviewed after identification of
this entity), other cardiomyopathy or myocarditis.
Examination of the propositus revealed an apparently
healthy, alert 13-year-old boy. Blood pressure was
115/70 mm Hg, and pulse 45 beats/min and irregular; the
remainder of the physical examination was normal. Chest
X-ray film, hemoglobin, white blood cell count, electrolytes
(including calcium and phosphorus), urea, liver function
tests, urinary vanilmandelic acid, electroencephalogram
(with respiratory and photic stimulation) and audiogram
were all normal. The electrocardiogram (ECG) (Fig. 2)
revealed irregular sinus bradycardia with shifting atrial
pacemaker, occasional junctional escapes, a short PR inter-
val, inverted T waves in leads V1–V3 (normal at this age), a
normal QRS complex and QTc intervals and prominent U
waves.
FURTHER INVESTIGATIONS AND
DEVELOPMENT OF THERAPEUTIC STRATEGY
Family members were screened for abnormalities associated
with known causes of sudden cardiac death. Written,
informed consent was obtained before exercise tests and
invasive procedures. Systematic serial testing was still unre-
ported in 1973 to 1974, but the finding that arrhythmias
could be induced in symptomatic family members led, ad
hoc, to such a protocol.
1) Electrocardiograms. Electrocardiograms were obtained in
10 family members.
2) Audiograms. Audiograms were obtained in nine family
members.
3) Exercise tests. Exercise tests were performed on the
propositus (13 times), his 20-year-old sister (nine times),
53-year-old father (four times) and 54-year-old mother
(once). Tests were first performed in the absence of
medications and subsequently during trials of various
medications or different doses of the same medication.
With resuscitation equipment at hand, exercise was
performed on a bicycle ergometer, and a modified V5
Abbreviations and Acronyms
A-H interval 5 atrium to His bundle interval
CSM 5 carotid sinus massage
ECG 5 electrocardiogram or
electrocardiographic
H-V interval 5 interval from His bundle deflection to
ventricular depolarization
ICD 5 implantable cardioverter-defibrillator
SUDS 5 sudden unexpected death syndrome
(please note that the words sound rather
generic, but SUDS applies to a special
form of nocturnal arrhythmic sudden
death in southeast Asian males)
VPC 5 ventricular premature complex
Figure 1. Family pedigree. Consistent with an autosonal dominant
trait with variable penetrance. Asterisk indicates episodes that
began by 1978 (age 30 years).
Figure 2. Electrocardiogram of the propositus.
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lead was recorded, usually at a paper speed of 50 mm/s,
although sometimes at 25 mm/s. The work load was
increased by 100 kilopond meters/min (KPM/min) every
1 to 2 min to the point of fatigue or bigeminal ventric-
ular arrhythmias. For reference, 150 KPM/min 5 25 W.
Some days several tests were performed after rest and
return to baseline heart rate.
Because little information was then available about
changes in the QT interval with exercise, 44 volunteers also
underwent exercise testing and served as control subjects;
these subjects were normal by history, ECG and physical
examination. The QT intervals in three subgroups—8 boys
age 12 to 19 years, 7 young women age 19 to 26 years and
10 men age 50 to 56 years—permitted comparison to the
intervals of the propositus, his sister and father, respectively.
The effects of propranolol (orally and intravenously),
verapamil and isoproterenol were tested in the propositus
and his 20-year-old sister; the propositus was also given oral
phenytoin. The father, given phenytoin (100 mg twice a
day) since 1960, was not tested while taking other medica-
tions.
4) Plasma catecholamines. Plasma catecholamines were mea-
sured (20) with strict attention to techniques of sampling
and handling of the specimens. Samples were drawn
from the propositus (twice), his 20-year-old sister and
father immediately after insertion of an intravenous line,
during exercise-induced arrhythmia and after the subject
had rested for 1 h after exercise.
5) Electrophysiological studies. Intracardiac electrophysi-
ologic recordings, including His bundle studies with
programmed electrical stimulation of the atrium and
ventricle, were carried out in the propositus and his
20-year-old and 27-year-old sisters using up to three
ventricular extrastimuli in the absence of antiarrhythmic
medications. Isoproterenol was infused at 5 mg/min
without extrastimulus testing. Right and left carotid
sinus massage (CSM) was done in the absence of
medications and after infusions of edrophonium, 10 mg;
blood pressure was measured during CSM.
6) Ambulatory ECG monitoring. Several ambulatory ECGs
were obtained while the propositus was in the hospital
and of the 20-year-old sister during a 72-h period while
she toured London.
7) Echocardiography. The propositus underwent M-mode
echocardiography.
RESULTS
1) Electrocardiograms. All four of the affected surviving
family members had sinus arrhythmia; three had prom-
inent U waves; and the propositus also had inverted T
waves in leads V1–V3 (normal for his age) and a
wandering atrial pacemaker. Three symptomatic mem-
bers had a short PR interval (0.11 to 0.12 s). The
youngest sister, 8 years old, although asymptomatic, had
a PR interval of 0.11 and sinus arrhythmia. All had
normal QT intervals at rest and (in those tested) during
exercise (Fig. 2).
2) Audiograms. Audiograms were normal in eight of nine
cases. An asymptomatic 18-year-old brother whose
ECG was normal had a unilateral high frequency deficit.
He remains asymptomatic.
3) Exercise tests. The propositus, his 20-year-old sister and
the father all developed ventricular tachyarrhythmias
with exercise in the absence of medications. The pattern
consisted of isolated ventricular premature complexes
(VPCs) progressing to bigeminy, to multifocal VPCs
and to symptomatic short bursts of polymorphic ventric-
ular tachycardia, as recorded in the propositus on his
initial test (Fig. 3). The father also developed two short
runs of supraventricular tachycardia. Subsequently, exer-
cise tests were stopped once ventricular bigeminy oc-
curred. Medications and doses were considered effective
if the subject was able to complete two exercise tests to
fatigue without ventricular tachycardia, couplets or bi-
geminy. The work loads and heart rates required to
produce ventricular arrhythmias in the propositus with
and without medication are summarized in Figure 4.
Intravenous propranolol (1.5 to 5 mg) prevented ven-
tricular arrhythmias in the three subjects tested, even at
high work loads and heart rates up to 160 beats/min. In
the propositus and his sister, oral propranolol in increas-
ing doses from 30 to 120 or 240 mg/day, respectively,
was incrementally effective at suppressing the appearance
of ventricular arrhythmias until higher work loads or
heart rates were attained. On 120 mg/day of propranolol
for the propositus and 240 mg/day for the sister, bigem-
inal ventricular rhythms occurred only at the point of
fatigue. Verapamil and phenytoin were less effective. On
phenytoin, the father had no further ventricular or
Figure 3. Exercise test in the propositus, showing increasing
numbers of extrasystoles with increasing work load. At 400
kilopond meters/min (KPM/min), there were up to four successive
polymorphic extrasystoles. The QTc interval remains normal.
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supraventricular tachycardia with exercise, although he
did have increasing numbers of VPCs. However, he
preferred to remain on phenytoin as his long-term
therapy. Compared with baseline, higher work loads
could be achieved before arrhythmias with oral propran-
olol.
Except with verapamil, the corrected QT intervals in-
creased with exercise beyond the normal limits prescribed by
Bazett’s formula (21). However, the QTs remained within
normal limits (62 SD) based on the mean values established
by the normal control groups used for this study (22) and
others (23–25).
Ventricular arrhythmias could also be provoked by emo-
tional stimuli. Approaching the 13-year-old propositus with
a needle for an intravenous drip frequently induced sinus
tachycardia and runs of VPCs and bigeminy. See additional
related comments below in the section on ambulatory
monitoring. Intravenous isoproterenol administered in the
exercise laboratory also produced ventricular arrhythmias
when the sinus rate exceeded 130 beats/min.
Plasma catecholamines. The fluctuations of the cat-
echolamines are shown in Figure 5. It has been debated (26)
whether beta-blockers can markedly increase the catechol-
amine levels. Because the 13-year-old and 20-year-old
siblings were on beta-blockers during the tests, their “true”
catecholamine levels may have been lower.
Electrophysiologic studies. In all three subjects, intracar-
diac electrophysiologic studies revealed normal A-H inter-
vals that became prolonged appropriately with increasing
pacing rates and in response to extrastimuli without a break
in the atrium to His bundle (A-H) curve. The interval from
His bundle deflection to ventricular depolarization (H-V
interval) was somewhat abbreviated at 25 ms and was
constant at all rates. The studies elicited no evidence of any
accessory pathway. Programmed stimulation failed to initi-
ate a tachycardia in any subject.
Isoproterenol (5 mg/min) provoked frequent VPCs in the
two sisters, with up to three beats of ventricular tachycardia.
These beats were all of left bundle branch block configura-
tion, but polymorphic with right, left and normal axes. The
sinus node response was somewhat blunted in the 27-year-
old sister (rate 111 beats/min) and propositus (rate 110
junctional), unlike the appropriate sinus tachycardias seen
with isoproterenol at the time of exercise testing. There was
no significant slowing or hypotension with CSM with or
without edrophonium and no significant slowing of the
sinus rate with verapamil.
Ambulatory ECG (Holter) monitoring. No tachyar-
rhythmias or VPCs were recorded in the propositus during
low level ambulatory activities in hospital. The 72 h of
Holter tapes in the 20-year-old woman revealed episodes of
sinus tachycardia, VPCs and bigeminy temporally related to
stressful events, such as this rural inhabitant had experi-
enced when confronted by one of the imposing escalators of
the London underground railway.
Echocardiogram. The echocardiogram in the propositus
was normal; in particular there was no evidence of chamber
enlargement or dysfunction, septal thickening or mitral
valve prolapse.
Summary of diagnostic and therapeutic strategy. No
structural or chemical abnormalities were identified, and the
family did not fit a known syndrome. The finding that
arrhythmias could be induced by exercise led to serial
testing. Three symptomatic family members underwent
electrophysiologic study (negative in all); three symptomatic
members had arrhythmias induced by exercise testing in the
absence of drugs, but not after graded increases of medica-
Figure 4. Serial exercise-pharmacologic testing. Effect of medica-
tions on work load–heart rate relations in the propositus. The end
point was fatigue or ventricular arrhythmias (bigeminal or more).
I.V. 5 intravenous; P.O. 5 oral.
Figure 5. Plasma catecholamines before (PRE), during (EX 5
exercise) and after exercise (POST). The propositus had catechol-
amine measurements with two exercise tests. Shaded areas repre-
sent the normal ranges.
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tions; and an asymptomatic member had no arrhythmias
induced. Other affected family members were then treated
by extrapolation with beta-blockers.
Follow-up. The family has been followed continually for
25 years since the serial exercise tests. One of the authors
(J.D.F.) corresponds yearly with the mother of the propos-
itus; every three to five years she completes a detailed chart.
All affected members were treated with propranolol or
phenytoin, or both, or the anticonvulsant primadone (n 5
1), and among these there have been no further episodes of
syncope. The 20-year-old sister of the propositus has had a
miscarriage of uncertain relation to propranolol therapy. A
brother of the propositus began to have syncopal spells in
1978 at age 30; he was treated with propranolol and has
since remained symptom-free. The son of the propositus
began to have syncopal spells in 1995, at age 11, and has
since remained asymptomatic on beta-blocker therapy.
DISCUSSION
Treatment based on serial exercise-pharmacologic testing
appears to be effective in this family with malignant ven-
tricular arrhythmias. The cause of the arrhythmias in this
family remains unclear. The short PR interval recorded in
several affected members received attention during detailed
electrophysiologic studies, but these showed only normal
decremental conduction. Sinus bradycardia with wandering
atrial pacemaker, prominent U waves and precipitation of
arrhythmias by emotional stress all occur in the prolonged
QT interval syndromes (2–4). Efforts to identify intermit-
tent QT interval prolongation were of no avail at rest,
during ordinary activities using Holter monitoring or during
exercise testing (25). The arrhythmias could not be defini-
tively related to elevated plasma catecholamines at times of
stress.
Similar nonfamilial arrhythmias. Very similar arrhyth-
mias, although sporadic rather than familial, were reported
by Coumel et al. (27) in four children, later expanded to a
series of 21 patients (28). The arrhythmias were triggered by
emotion and effort and controlled by beta-blockers, some-
times with the need for supplementary amiodarone. The
authors postulated that the tachycardias arose because of an
undue sensitivity to catecholamines: as with our patients,
the infusion of isoproterenol induced arrhythmias exactly
like those seen after emotional stress or exertion. The
ventricular arrhythmias are polymorphic and therefore re-
semble “torsade de pointes” (29). Beta-blockers appeared
effective; recurrent syncope and two deaths over a seven-year
mean follow-up were attributed to lapses in therapy (28).
Other reports (19) and those summarized by Vlay (30) show
the spectrum of catecholamine-sensitive ventricular tachy-
cardia. Variations or oscillations in sympathetic and para-
sympathetic activity have long been implicated in arrhyth-
mogenesis (31–35). In a preliminary report, such oscillations
have been recorded in a patient with idiopathic ventricular
tachycardia using power spectral analysis (36). Among the
series of 15 patients with sudden cardiac death and poly-
morphous ventricular tachycardia reported by Eisenberg et
al. (37), four had their arrhythmia induced by treadmill
testing or isoproterenol infusion, or both, and all were
treated with the beta-blocker antenolol, but one died
suddenly after 66 months. The family in our report is also
reminiscent of the idiopathic ventricular fibrillation syn-
drome reported by Viskin et al. (38). The latter, however,
was not familial and had their arrhythmias induced at
electrophysiologic testing.
Familial ventricular arrhythmias. Reports of familial
tachyarrhythmias in the absence of structural heart disease
or associated known syndromes have shown many variations
(Table 1). Some have featured a tendency toward sinus
bradycardia (15,19), U waves (13,15), a short PR interval
(13,15), ventricular arrhythmias with exercise or exercise
testing (12–14,16,17,19), emotion (12,13,19) or isoproter-
enol infusion (14,17). In some families the arrhythmias are
inducible by programmed stimulation (15,16). Beta-
blockers have proved effective in some (13,14,16) but not all
patients (15,17,19). There seems to be a preponderance of
reports from parts of the world where the population is of
British or northern European background (Table 1).
Recent contributions—molecular and genetic. Recent
interest in polymorphic ventricular tachycardias in the
absence of structural heart disease has centered around
genetic and molecular changes resulting in phase 2 reentry
and early afterdepolarizations (6,39–45). These often lead
to the characteristic changes seen in the Brugada syndrome
(39–42,44), sudden unexpected death syndrome (SUDS)
(43,44) or the long QT interval syndromes (45). Manifes-
tation or expression of these syndromes may depend on
changes in autonomic tone, including changes brought
about by exercise or emotional stress. Procainamide, flecain-
ide and other drugs may elicit the characteristic ECG
changes of the Brugada syndrome (39–42,44), and this
might be applicable to the ongoing follow-up of this family.
Otherwise, the family in the present report does not exhibit
any ECG changes characteristic of these syndromes, even
subtle variations such as those described by von Bernuth et
al. (46), where the QT interval is normal at rest but fails to
shorten with exercise. Indeed, it has been suggested “that
cardiac conditions comparable to those in the prolonged QT
syndromes may exist without that ECG feature, for example
with unequal sympathetic influence on areas of overlap and
exclusive left-sided innervation” (47). That would amount
to a kind of “long QT syndrome without a long QT
interval,” and we can only speculate whether this might
apply to the present family.
Other data. There were no gross pathologic changes in this
family. Abnormal or hypoplastic conduction systems have
also been implicated in unexpected sudden death in appar-
ently healthy young persons (17). The hearts available for
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autopsy in this family were not suitable for a subsequent
detailed study of the conduction system, although electro-
physiologic studies of conduction and exercise heart rate
response were normal. Techniques such as cardiac magnetic
resonance imaging were not available during the investiga-
tion of this family.
Measures of efficacy: serial testing and time. In the
treatment of potentially lethal arrhythmias, it is essential to
assess the effectiveness of any proposed therapy before
discharge from the hospital. Serial exercise-pharmacologic
testing has had favorable short-term results in a mixed
group of patients with exercise-induced ventricular arrhyth-
mias (48–50). Verapamil (51) was not as effective as
beta-blockers in the present family.
The early favorable response of the family in this report
led directly to the use of serial electrophysiologic-
pharmacologic testing in patients with arrhythmias inducible
in the electrophysiology laboratory (52). There is at present a
degree of skepticism regarding the effectiveness of therapy
based on serial exercise testing, serial Holter monitoring or
serial electrophysiologic studies. As a consequence, many
patients with potentially fatal cardiac arrhythmias are treated
with an implantable-cardioverter defibrillator (ICD), and in-
deed both the efficacy of the ICD and the increasing ease of
implantation make the ICD the current gold standard. The
effective long-term management of this family, continuing
beyond two decades, indicates that alternatives to the ICD may
be appropriate in selected instances. Serial exercise testing,
similar to what we report, may be useful in some rhythm
disorders provoked by emotion, catecholamines or exercise.
Acknowledgments
The authors gratefully acknowledge the assistance of Dr. E.
Zeidifard of the Pulmonary Laboratory at Hammersmith
Hospital, London; Dr. L. Zohman of the Work Physiology
Unit at Montefiore Hospital, New York; Ms. Ida Morlock;
and the nurses, doctors, technicians and volunteers at both
institutions who assisted with, or provided data for, the
exercise tests.
Reprint requests and correspondence: Dr. John D. Fisher,
Cardiology Division, Arrhythmia Offices, N2, Montefiore Medi-
cal Center, 111 East 210th Street, Bronx, New York 10467.
REFERENCES
1. Nava A, Thiene G, Canciani B, et al. Familial occurrence of right
ventricular dysplasia: a study involving nine families. J Am Coll
Cardiol 1988;12:1222–8.
2. Corrado D, Basso C, Thiene G, et al. Spectrum of clinicopathologic
manifestations of arrhythmogenic right ventricular cardiomyopathy/
dysplasia: a multicenter study. J Am Coll Cardiol 1997;30:1512–20.
3. Marcus FI, Fontaine G. Arrhythmogenic right ventricular dysplasia/
cardiomyopathy: a review. PACE 1995;18:1298–314.
4. Marian AJ, Roberts R. Molecular genetic basis of hypertrophic
cardiomyopathy: genetic markers for sudden cardiac death. J Cardio-
vasc Electrophysiol 1998;9:88–99.
5. Maron BJ, Shirani J, Poliac LC, Mathenge R, Roberts WC, Mueller
FO. Sudden death in young competitive athletes: clinical, demo-
graphic, and pathological profiles. JAMA 1996;276:199–204.
6. Corrado D, Nava A, Buja G, et al. Familial cardiomyopathy underlies
syndrome of right bundle branch block, ST segment elevation and
sudden death. J Am Coll Cardiol 1996;27:443–8.
7. Jevell A, Lange-Nielsen F. Congenital deaf-mutism, functional heart
disease with prolongation of the QT interval and sudden death. Am
Heart J 1957;54:59–68.
8. Romano C, Germme G, Pongiglione R. Aritmie cardiache rare
dell’eta’ pediatrica. Clin Pediatr (Bologna) 1963;45:656–83.
9. Ward OC. A new familial cardiac syndrome in children. J Irish Med
Assoc 1964;54:103–7.
10. Moss AJ, Zareba W, Benhorin J, et al. ECG T-wave patterns in
genetically distinct forms of the hereditary long QT syndrome.
Circulation 1995;92:2929–34.
11. Roden DM, Lazzara R, Rosen M, Schwartz PJ, Towbin J, Vincent
GM. Multiple mechanisms in the long-QT syndrome, current knowl-
edge, gaps, and future directions. Circulation 1996;94:1996–2012.
12. Green JR, Korovetz MJ, Shanklin DR, DeVito JJ, Taylor WJ. Sudden
unexpected death in three generations. Arch Intern Med 1969;124:
359–63.
13. McRae JR, Wagner GS, Rogers MC, Canent RV. Paroxysmal familial
ventricular fibrillation. J Pediatr 1974;84:815–8.
14. Sacks HS, Matisonn R, Kennelly BM. Familial paroxysmal ventricular
tachycardia of unknown etiology. Proc Royal Soc Med 1975;68:305–6.
15. Wren C, Rowland E, Burn J, Campbell RWF. Familial ventricular
tachycardia: a report of four families. Br Heart J 1990;63:169–74.
16. Chambers JW, Denes P, Dahl W, et al. Familial sudden death
syndrome with an abdominal signal-averaged electrocardiogram as a
potential marker. Am Heart J 1995;130:318–23.
17. Brookfield L, Bharati S, Denes P, Haklstead D, Lev M. Familial
sudden death: report of a case and review of the literature. Chest
1988;124:359–63.
18. Rubin DA, O’Keefe A, Kay RH, McAllister A, Mendelson DM.
Autosomal dominant inherited ventricular tachycardia. Am Heart J
1992;123:1082–4.
19. von Bernuth G, Bernsau U, Getheil H, et al. Tachyarrhythmic
syncopes in children with structurally normal hearts with and without
QT-prolongation in the electrocardiogram. Eur J Pediatr 1982;138:
206–10.
20. McCullough H. Semi-automated method for the differential determi-
nation of plasma catecholamines. J Clin Pathol 1968;21:759–63.
21. Bazett HC. An analysis of the time relationship of the electrocardio-
gram. Heart 1920;7:353–70.
22. Fisher JD. The normal QT interval during exercise (abstr). Circulation
1979;236:59–60.
23. Sarma JSM, Sarma RJ, Bilitch M, Katz D, Song SL. An exponential
formula for heart rate dependence of QT interval during exercise and
cardiac pacing in humans: reevaluation of Bazett’s formula. Am J
Cardiol 1984;54:103–8.
24. Wolthuis RA, Hopkirk A, Keiser N, Fischer JR Jr. T-waves in the
exercise ECG: their location and occurrence. IEEE Trans Biomed
Eng 1979;26:639–43.
25. Bucsenez D, von Bernuth G. The QT interval during exercise in
healthy children 6–14 years old. J Electrocardiol 1989;22:17–9.
26. Irving MH, Britton BJ, Wood WG, Padgham C, Carruthers M.
Effects of beta-adrenergic blockade on plasma catecholamines in
exercise. Nature 1974;248:531–3.
27. Coumel P, Fidelle J, Lucet V, Attuel P, Bouvrain Y. Catecholamine-
induced severe ventricular arrhythmias with Adams-Stokes syndrome
in children: report of four cases. Br Heart J 1978;40 Suppl:28–37.
28. Leenhardt A, Lucet V, Denjoy I, Grau F, Ngoc DD, Coumel P.
Catecholaminergic polymorphic ventricular tachycardia in children.
Circulation 1995;91:1512–9.
29. Krikler DM, Curry PVL. “Torsade de pointes”: an atypical ventricular
tachycardia. Br Heart J 1976;38:117–20.
30. Vlay SC. Catecholamine-sensitive ventricular tachycardia. Am Heart J
1987;114:455–61.
31. Wellens HJJ, Vermeulen A, Durrer D. Ventricular fibrillation occur-
ring on arousal from sleep by auditory stimuli. Circulation 1972;46:
661–5.
32. Kolman BS, Verrier RL, Lown B. The effect of vagus nerve stimula-
tion upon vulnerability of the canine ventricle: role of sympathetic-
parasympathetic interactions. Circulation 1975;52:578–85.
2021JACC Vol. 34, No. 7, 1999 Fisher et al.
December 1999:2015–22 Familial Ventricular Arrhythmias
33. Schwartz PJ, Snebold NG, Brown AM. Effects of unilateral cardiac
sympathetic denervation on the ventricular fibrillation threshold. Am J
Cardiol 1976;37:1034–40.
34. Kuo CS, Surawicz B. Ventricular monophasic action potential changes
associated with neurogenic T wave abnormalities and isoproterenol
administration in dogs. Am J Cardiol 1976;38:170–7.
35. Hageman GR, Goldberg JM, Armour JA, Randall WC. Cardiac
dysrhythmias induced by autonomic nerve stimulation. Am J Cardiol
1973;32:823–30.
36. Sobh JF, Barbieri R, Triedman JK, Saul P. Periodic ventricular
tachycardia in a 4-year-old boy: evidence for sympathetic triggering
using frequency domain analysis (abstr). PACE 1997;20:512.
37. Eisenberg SJ, Scheinman MM, Dullet NK, et al. Sudden cardiac death
and polymorphous ventricular tachycardia in patients with normal QT
intervals and normal systolic cardiac function. Am J Cardiol 1995;75:
687–92.
38. Viskin S, Lesh MD, Eldar M, et al. Mode of onset of malignant
ventricular arrhythmias in idiopathic ventricular fibrillation. J Cardio-
vasc Electrophysiol 1997;8:1115–20.
39. Brugada P, Brugada J. Right bundle branch block, persistent ST
segment elevation and sudden cardiac death: a distinct clinical and
electrocardiographic syndrome. J Am Coll Cardiol 1992;20:1391–6.
40. Scheinman MM. Is the Brugada syndrome a distinct clinical entity?
J Cardiovasc Electrophysiol 1997;8:332–6.
41. Brugada J, Brugada P. Further characterization of the syndrome of
right bundle branch block, ST segment elevation, and sudden cardiac
death. J Cardiovasc Electrophysiol 1997;8:325–31.
42. Brugada J, Brugada R, Brugada P. Right bundle-branch block and
ST-segment elevation in leads V1 through V3—marker for sudden
death in patients without demonstrable structural heart disease. Cir-
culation 1998;97:457–60.
43. Nademanee K, Veerakul G, Nimmannit S, et al. Arrhythmogenic
marker for the sudden unexplained death syndrome in Thai men.
Circulation 1997;96:2595–600.
44. Yan GX, Antzelevitch C. Cellular basis for the electrocardiographic J
wave. Circulation 1996;93:372–9.
45. El-Sherif N, Caref EB, Yin H, Restivo M. The electrophysiological
mechanism of ventricular arrhythmias in the long QT syndrome—
tridimensional mapping of activation and recovery patterns. Circ Res
1996;79:474–92.
46. von Bernuth G, Belz GG, Evertz W, Strauch M. QTU abnormalities,
sinus bradycardia, and Adams-Stokes attacks due to ventricular ar-
rhythmia. Acta Paediatr Scand 1973;62:675–9.
47. Levitt B, Cagin N, Kleid J, Somberg J, Gillis R. Role of the nervous
system in the genesis of cardiac rhythm disorders. Am J Cardiol
1976;37:1111–3.
48. Graboys TB, Lown B, Podrid P, DeSilva R. Long-term survival of
patients with malignant ventricular arrhythmias treated with antiar-
rhythmic drugs. Am J Cardiol 1982;50:437–43.
49. Saini V, Graboys TB, Towne V, Lown B. Reproducibility of exercise-
induced ventricular arrhythmia in patients undergoing evaluation for
malignant ventricular arrhythmia. Am J Cardiol 1989;63:697–701.
50. Woelfel A, Foster JR, Simpson RJ, Gettes LS. Reproducibility and
treatment of exercise-induced ventricular tachycardia. Am J Cardiol
1984;53:751–6.
51. Woelfel A, Foster JR, McAllister RG Jr., Simpson RJ Jr., Gettes LS.
Efficacy of verapamil in exercise-induced ventricular tachycardia. Am J
Cardiol 1985;56:292–7.
52. Fisher JD, Cohen HL, Mehra R, Altschuler H, Escher DJW, Furman
S. Cardiac pacing and pacemakers II: serial electrophysiologic-
pharmacologic testing for control of recurrent tachyarrhythmias. Am
Heart J 1977;93:658–68.
2022 Fisher et al. JACC Vol. 34, No. 7, 1999
Familial Ventricular Arrhythmias December 1999:2015–22
